loading
前日終値:
$7.37
開ける:
$7.37
24時間の取引高:
157.17K
Relative Volume:
0.92
時価総額:
$281.00M
収益:
$128.45M
当期純損益:
$6.54M
株価収益率:
150.00
EPS:
0.05
ネットキャッシュフロー:
$-8.79M
1週間 パフォーマンス:
-5.78%
1か月 パフォーマンス:
+10.95%
6か月 パフォーマンス:
+16.28%
1年 パフォーマンス:
+7.45%
1日の値動き範囲:
Value
$7.33
$7.54
1週間の範囲:
Value
$7.28
$8.11
52週間の値動き範囲:
Value
$4.76
$8.85

Lifecore Biomedical Inc Stock (LFCR) Company Profile

Name
名前
Lifecore Biomedical Inc
Name
セクター
Healthcare (1137)
Name
電話
(952) 368-4300
Name
住所
3515 LYMAN BOULEVARD, CHASKA
Name
職員
406
Name
Twitter
Name
次回の収益日
2025-10-27
Name
最新のSEC提出書
Name
LFCR's Discussions on Twitter

LFCR を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Drug Manufacturers - Specialty & Generic icon
LFCR
Lifecore Biomedical Inc
7.50 276.13M 128.45M 6.54M -8.79M 0.05
Drug Manufacturers - Specialty & Generic icon
ZTS
Zoetis Inc
121.25 51.07B 9.40B 2.65B 2.24B 5.935
Drug Manufacturers - Specialty & Generic icon
TAK
Takeda Pharmaceutical Co Adr
14.30 44.42B 29.63B 260.53M 5.51B 0.0788
Drug Manufacturers - Specialty & Generic icon
HLN
Haleon Plc Adr
9.85 42.75B 14.26B 1.98B 2.47B 0.4327
Drug Manufacturers - Specialty & Generic icon
TEVA
Teva Pharmaceutical Industries Ltd Adr
24.21 27.86B 16.70B -157.13M 1.19B -0.1446
Drug Manufacturers - Specialty & Generic icon
UTHR
United Therapeutics Corp
473.19 20.44B 3.08B 1.24B 1.07B 25.61

Lifecore Biomedical Inc Stock (LFCR) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-09-04 開始されました KeyBanc Capital Markets Sector Weight
2025-05-21 開始されました William Blair Outperform
2024-09-05 開始されました Craig Hallum Buy
2024-08-28 ダウングレード Barrington Research Outperform → Mkt Perform
2023-03-20 ダウングレード Stephens Overweight → Equal-Weight

Lifecore Biomedical Inc (LFCR) 最新ニュース

pulisher
Nov 20, 2025

Lifecore Biomedical at Stephens Annual Investment Conference: Strategic Growth Path By Investing.com - Investing.com Canada

Nov 20, 2025
pulisher
Nov 20, 2025

Can Lifecore Biomedical Inc. stock surprise with earnings upsideQuarterly Performance Summary & AI Powered Buy and Sell Recommendations - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Lifecore Biomedical Inc. (LDE) stock benefit from sector leadership2025 Breakouts & Breakdowns & Technical Pattern Recognition Alerts - newser.com

Nov 20, 2025
pulisher
Nov 20, 2025

Will Lifecore Biomedical Inc. stock benefit from green energy trendsProfit Target & Daily Oversold Stock Bounce Ideas - newser.com

Nov 20, 2025
pulisher
Nov 19, 2025

Is Lifecore Biomedical Inc. stock ready for breakoutStop Loss & Short-Term High Return Strategies - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

What candlestick patterns are forming on Lifecore Biomedical Inc.July 2025 Selloffs & Safe Entry Momentum Tips - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

Should I hold or sell Lifecore Biomedical Inc. stock in 2025July 2025 Recap & Capital Protection Trade Alerts - newser.com

Nov 19, 2025
pulisher
Nov 19, 2025

How to interpret RSI for Lifecore Biomedical Inc. stock2025 Bull vs Bear & Consistent Return Investment Signals - newser.com

Nov 19, 2025
pulisher
Nov 18, 2025

How Lifecore Biomedical Inc. stock benefits from strong dollarMarket Rally & Expert-Curated Trade Recommendations - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Why pension funds invest in Lifecore Biomedical Inc. (LDE) stockBull Run & Technical Confirmation Trade Alerts - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Will Lifecore Biomedical Inc. (LDE) stock see insider accumulation - newser.com

Nov 18, 2025
pulisher
Nov 18, 2025

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Lifecore Biomedical, Inc. (LFCR) And Encourages Shareholders to Reach Out - ACCESS Newswire

Nov 18, 2025
pulisher
Nov 18, 2025

Lifecore Biomedical at Jefferies London: Strategic Growth Unveiled By Investing.com - Investing.com Canada

Nov 18, 2025
pulisher
Nov 17, 2025

Lifecore Biomedical, Inc. Announces Fiscal Year Change and Strategic Developments - TradingView

Nov 17, 2025
pulisher
Nov 16, 2025

Real time pattern detection on Lifecore Biomedical Inc. stockQuarterly Risk Review & Weekly Chart Analysis and Trade Guides - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Will Lifecore Biomedical Inc. (LDE) stock gain from lower interest ratesQuarterly Market Summary & Risk Managed Investment Strategies - newser.com

Nov 16, 2025
pulisher
Nov 16, 2025

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Lifecore Biomedical, Inc. (LFCR) and Encourages Shareholders to Learn More About the Investigation - ACCESS Newswire

Nov 16, 2025
pulisher
Nov 16, 2025

Lifecore Biomedical (NASDAQ:LFCR) Adds US$54m to Market Cap in the Past 7 Days, Though Investors From Five Years Ago Are Still Down 19% - 富途牛牛

Nov 16, 2025
pulisher
Nov 16, 2025

Market reaction to Lifecore Biomedical Inc.’s recent news2025 Sector Review & Safe Entry Point Alerts - newser.com

Nov 16, 2025
pulisher
Nov 15, 2025

Is it too late to sell Lifecore Biomedical Inc.Market Growth Review & Capital Protection Trading Alerts - newser.com

Nov 15, 2025
pulisher
Nov 14, 2025

Is Lifecore Biomedical Inc. stock affected by interest rate hikesMarket Activity Report & Daily Risk Controlled Trade Plans - Fundação Cultural do Pará

Nov 14, 2025
pulisher
Nov 14, 2025

Is Lifecore Biomedical Inc. (LDE) stock undervalued after correctionWeekly Loss Report & Consistent Return Strategy Ideas - newser.com

Nov 14, 2025
pulisher
Nov 13, 2025

Will Lifecore Biomedical Inc. (LDE) stock recover faster than industryQuarterly Profit Summary & Reliable Intraday Trade Alerts - newser.com

Nov 13, 2025
pulisher
Nov 13, 2025

Lifecore Biomedical, Inc. (LFCR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - ACCESS Newswire

Nov 13, 2025

Lifecore Biomedical Inc (LFCR) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading

Lifecore Biomedical Inc (LFCR) インサイダートレーディング

インサイダートレーディング 関係 日付 取引 コスト #株式 値 ($) #株式総数
English Aron R.
10% Owner
May 28 '25
Sale
7.12
150,419
1,071,555
264,180
English Aron R.
10% Owner
May 23 '25
Sale
6.75
96,137
649,386
1,554,103
English Aron R.
10% Owner
May 13 '25
Sale
7.00
12,334
86,353
1,650,240
English Aron R.
10% Owner
May 12 '25
Sale
7.03
45,698
321,426
1,662,574
English Aron R.
10% Owner
May 08 '25
Sale
7.00
5,098
35,693
1,708,972
English Aron R.
10% Owner
May 09 '25
Sale
7.00
700
4,900
1,708,272
English Aron R.
10% Owner
May 05 '25
Sale
7.08
24,543
173,831
1,730,618
English Aron R.
10% Owner
May 07 '25
Sale
7.01
15,847
111,099
1,714,070
English Aron R.
10% Owner
May 06 '25
Sale
7.05
701
4,940
1,729,917
Josephs Paul
Chief Executive Officer
Jan 08 '25
Buy
5.74
17,000
97,580
559,717
$34.22
price up icon 1.75%
$21.99
price up icon 3.48%
drug_manufacturers_specialty_generic RDY
$13.96
price up icon 0.40%
$10.21
price up icon 0.25%
$142.06
price up icon 2.28%
$472.25
price down icon 0.39%
大文字化:     |  ボリューム (24 時間):